119 related articles for article (PubMed ID: 2541421)
21. Alpha-melanocyte-stimulating hormone exhibits target cell selectivity in its capacity to affect interleukin 1-inducible responses in vivo and in vitro.
Daynes RA; Robertson BA; Cho BH; Burnham DK; Newton R
J Immunol; 1987 Jul; 139(1):103-9. PubMed ID: 3495595
[TBL] [Abstract][Full Text] [Related]
22. Synthesis of tritium labeled Ac-[Nle4, D-Phe7]-alpha-MSH4-11-NH2: a superpotent melanotropin with prolonged biological activity.
Wilkes BC; Hruby VJ; Yamamura HI; Akiyama K; Castrucci AM; Hadley ME; Andrews JR; Wan YP
Life Sci; 1984 Mar; 34(10):977-84. PubMed ID: 6608041
[TBL] [Abstract][Full Text] [Related]
23. The role of calcium in MSH stimulated melanosome dispersion.
Lucas AM; Thody AJ; Shuster S
Peptides; 1987; 8(6):955-60. PubMed ID: 2831522
[TBL] [Abstract][Full Text] [Related]
24. Structure-activity relationships of [Nle4, D-Phe7]alpha-MSH. Discovery of a tripeptidyl agonist exhibiting sustained bioactivity.
Sawyer TK; Castrucci AM; Staples DJ; Affholter JA; De Vaux A; Hruby VJ; Hadley ME
Ann N Y Acad Sci; 1993 May; 680():597-9. PubMed ID: 8390200
[No Abstract] [Full Text] [Related]
25. Enzymological studies of melanotropins.
Castrucci AM; Hadley ME; Sawyer TK; Hruby VJ
Comp Biochem Physiol B; 1984; 78(3):519-24. PubMed ID: 6332706
[TBL] [Abstract][Full Text] [Related]
26. Biological activity, binding, and metabolic fate of Ac-[Nle4, D-Phe7]alpha-MSH4-11NH2 with the F1 variant of B16 melanoma cells.
Panasci LC; McQuillan A; Kaufman M
J Cell Physiol; 1987 Jul; 132(1):97-103. PubMed ID: 3110178
[TBL] [Abstract][Full Text] [Related]
27. Characterisation of the melanocortin 4 receptor by radioligand binding.
Schiöth HB; Muceniece R; Wikberg JE
Pharmacol Toxicol; 1996 Sep; 79(3):161-5. PubMed ID: 8884876
[TBL] [Abstract][Full Text] [Related]
28. In vivo evaluation of 99mTc/188Re-labeled linear alpha-melanocyte stimulating hormone analogs for specific melanoma targeting.
Chen J; Giblin MF; Wang N; Jurisson SS; Quinn TP
Nucl Med Biol; 1999 Aug; 26(6):687-93. PubMed ID: 10587108
[TBL] [Abstract][Full Text] [Related]
29. NMR and quenched molecular dynamics studies of superpotent linear and cyclic alpha-melanotropins.
Al-Obeidi F; O'Connor SD; Job C; Hruby VJ; Pettitt BM
J Pept Res; 1998 Jun; 51(6):420-31. PubMed ID: 9650716
[TBL] [Abstract][Full Text] [Related]
30. Cyclic lactam analogues of Ac-[Nle4]alpha-MSH4-11-NH2.
Sugg EE; Castrucci AM; Hadley ME; van Binst G; Hruby VJ
Biochemistry; 1988 Oct; 27(21):8181-8. PubMed ID: 2852955
[TBL] [Abstract][Full Text] [Related]
31. Separation and partial characterization by high-performance liquid chromatography and radioimmunoassay of different forms of melanocyte-stimulating hormone from fish (Cyprinidae) neurointermediate lobes.
Follénius E; Van Dorsselaer A; Meunier A
Gen Comp Endocrinol; 1985 Feb; 57(2):198-207. PubMed ID: 2984088
[TBL] [Abstract][Full Text] [Related]
32. Calcium-dependent prolonged effects on melanophores of [4-norleucine, 7-D-phenylalanine]-alpha-melanotropin.
Hadley ME; Anderson B; Heward CB; Sawyer TK; Hruby VJ
Science; 1981 Aug; 213(4511):1025-7. PubMed ID: 6973820
[TBL] [Abstract][Full Text] [Related]
33. The melanocyte-stimulating hormone (MSH) receptor in M2R mouse melanoma tumours: solubilization and properties of the receptor-MSH complex and its covalently crosslinked conjugate.
Shafir I; Schmidt-Sole J; Shai E; Salomon Y
Melanoma Res; 1993 Jun; 3(3):157-68. PubMed ID: 8400853
[TBL] [Abstract][Full Text] [Related]
34. Electrospray mass spectrometric analysis of new alpha-MSH analogues carrying nitrogen mustard at their amino terminus.
Van Beeumen J; Devreese B; Ghanem G; Lejeune F; Deknop C; Faignet C; Toch I; Jacquemotte F
Pept Res; 1994; 7(1):7-12. PubMed ID: 8019062
[TBL] [Abstract][Full Text] [Related]
35. Alpha-melanocyte-stimulating hormone (MSH) and [Nle4,D-Phe7]-alpha-MSH: effects on core temperature in rats.
Raible LH; Knickerbocker D
Pharmacol Biochem Behav; 1993 Mar; 44(3):533-8. PubMed ID: 8383852
[TBL] [Abstract][Full Text] [Related]
36. [Nle4-D-Phe7]-alpha-melanocyte-stimulating hormone significantly increased pigmentation and decreased UV damage in fair-skinned Caucasian volunteers.
Barnetson RS; Ooi TK; Zhuang L; Halliday GM; Reid CM; Walker PC; Humphrey SM; Kleinig MJ
J Invest Dermatol; 2006 Aug; 126(8):1869-78. PubMed ID: 16763547
[TBL] [Abstract][Full Text] [Related]
37. [Alpha-melanocyte-stimulating hormone. From bench to bedside].
Böhm M; Luger TA
Hautarzt; 2010 Jun; 61(6):497-504. PubMed ID: 20512306
[TBL] [Abstract][Full Text] [Related]
38. Alpha-melanocyte-stimulating hormone and endothelin-1 have opposing effects on melanocyte adhesion, migration, and pp125FAK phosphorylation.
Scott G; Cassidy L; Abdel-Malek Z
Exp Cell Res; 1997 Nov; 237(1):19-28. PubMed ID: 9417862
[TBL] [Abstract][Full Text] [Related]
39. Transdermal delivery of a melanotropic peptide hormone analogue.
Dawson BV; Hadley ME; Kreutzfeld K; Dorr RT; Hruby VJ; Al-Obeidi F; Don S
Life Sci; 1988; 43(14):1111-7. PubMed ID: 2845208
[TBL] [Abstract][Full Text] [Related]
40. Design of potent linear alpha-melanotropin 4-10 analogues modified in positions 5 and 10.
Al-Obeidi F; Hruby VJ; Castrucci AM; Hadley ME
J Med Chem; 1989 Jan; 32(1):174-9. PubMed ID: 2535874
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
